These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3535621)

  • 1. The effect of phenylpropanolamine on female stress urinary incontinence.
    Lehtonen T; Rannikko S; Lindell O; Talja M; Wuokko E; Lindskog M
    Ann Chir Gynaecol; 1986; 75(4):236-41. PubMed ID: 3535621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.
    Ek A; Andersson KE; Gullberg B; Ulmsten U
    Zentralbl Gynakol; 1980; 102(15):839-44. PubMed ID: 7006273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients.
    Collste L; Lindskog M
    Urology; 1987 Oct; 30(4):398-403. PubMed ID: 3310369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of urethral closure function in women with stress urinary incontinence.
    Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
    J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    Robinson D; Cardozo L; Terpstra G; Bolodeoku J;
    BJU Int; 2007 Oct; 100(4):840-5. PubMed ID: 17822465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urethral pressure profile: is it affected by position?
    Dörflinger A; Gorton E; Stanton S; Dreher E
    Neurourol Urodyn; 2002; 21(6):553-7. PubMed ID: 12382246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a long acting GnRH analogue or placebo on plasma LH/FSH, urethral pressure profiles and clinical signs of urinary incontinence due to Sphincter mechanism incompetence in bitches.
    Reichler IM; Jöchle W; Piché CA; Roos M; Arnold S
    Theriogenology; 2006 Sep; 66(5):1227-36. PubMed ID: 16672159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
    Nijman RJ; Borgstein NG; Ellsworth P; Djurhuus JC
    J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
    Roehrborn CG; Abrams P; Rovner ES; Kaplan SA; Herschorn S; Guan Z
    BJU Int; 2006 May; 97(5):1003-6. PubMed ID: 16643482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of maximum urethral closure pressure, urethral hypermobility and urethral incompetence in the diagnosis of clinically significant female genuine stress incontinence.
    Schick E; Dupont C; Bertrand PE; Jolivet-Tremblay M; Tessier J
    J Urol; 2004 May; 171(5):1871-5. PubMed ID: 15076296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence.
    Richter KP; Ling GV
    J Am Vet Med Assoc; 1985 Sep; 187(6):605-11. PubMed ID: 4086368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correlation of the severity of stress urinary incontinence with static and stress urethral pressure profiles].
    Masuda H; Yamada T; Nagamatsu H; Nagahama K; Kawakami S; Watanabe T; Negishi T
    Hinyokika Kiyo; 1994 Mar; 40(3):209-13. PubMed ID: 8178737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic and morphologic changes in the lower portion of the urogenital tract after administration of estriol alone and in combination with phenylpropanolamine in sexually intact and spayed female dogs.
    Hamaide AJ; Grand JG; Farnir F; Le Couls G; Snaps FR; Balligand MH; Verstegen JP
    Am J Vet Res; 2006 May; 67(5):901-8. PubMed ID: 16649928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 16. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation.
    Fossberg E; Beisland HO; Lundgren RA
    Urol Int; 1983; 38(5):293-9. PubMed ID: 6685364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.
    DuBeau CE; Khullar V; Versi E
    Neurourol Urodyn; 2005; 24(1):13-20. PubMed ID: 15570576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of urethral resistance pressure with maximum urethral closure pressure and stress incontinence.
    Kuhn A; Kuhn P; Dreher E
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):116-20. PubMed ID: 17618730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W
    Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
    Rovner ES; Rackley R; Nitti VW; Wang JT; Guan Z;
    Urology; 2008 Sep; 72(3):488-93. PubMed ID: 18639327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.